ES8407012A1 - Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c. - Google Patents

Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.

Info

Publication number
ES8407012A1
ES8407012A1 ES522561A ES522561A ES8407012A1 ES 8407012 A1 ES8407012 A1 ES 8407012A1 ES 522561 A ES522561 A ES 522561A ES 522561 A ES522561 A ES 522561A ES 8407012 A1 ES8407012 A1 ES 8407012A1
Authority
ES
Spain
Prior art keywords
derivatives
cyclic peptides
alkyl
hydrogen
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES522561A
Other languages
English (en)
Other versions
ES522561A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Publication of ES8407012A1 publication Critical patent/ES8407012A1/es
Publication of ES522561A0 publication Critical patent/ES522561A0/es
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20Bacteria; Culture media therefor
    • C12N1/205Bacterial isolates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/08Linear peptides containing only normal peptide links having 12 to 20 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/045Actinoplanes
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/01Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/62Streptosporangium
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/19Antibiotic
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00Peptide or protein sequence
    • Y10S930/01Peptide or protein sequence
    • Y10S930/27Cyclic peptide or cyclic protein

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA PREPARACION DE UN DERIVADO PEPTIDICO CICLICO A-21978C DE FORMULA GENERAL (I), Y LAS SALES FARMACEUTICAMENTE ACEPTABLES DEL MISMO.CONSISTE EN HACER REACCIONAR EL NUCLEO A-21978C DE FORMULA GENERAL (II) O UN DERIVADO APROPIADAMENTE PROTEGIDO DEL MISMO O UN PRODUCTO PROTECTOR DEL AMINO O UNA SAL FARMACEUTICAMENTE ACEPTABLE DEL MISMO, CON UN AGENTE ACILANTE DE FORMULA GENERAL (III) O CON UN DERIVADO DEL MISMO.DE APLICACION EN LA PREPARACION DE ANTIBIOTICOS.
ES522561A 1982-05-21 1983-05-19 Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c. Granted ES522561A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/380,498 US4399067A (en) 1982-05-21 1982-05-21 Derivatives of A-21978C cyclic peptides

Publications (2)

Publication Number Publication Date
ES8407012A1 true ES8407012A1 (es) 1984-09-01
ES522561A0 ES522561A0 (es) 1984-09-01

Family

ID=23501401

Family Applications (1)

Application Number Title Priority Date Filing Date
ES522561A Granted ES522561A0 (es) 1982-05-21 1983-05-19 Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.

Country Status (15)

Country Link
US (1) US4399067A (es)
KR (1) KR860002185B1 (es)
AT (1) AT380022B (es)
CA (1) CA1215043A (es)
DD (1) DD209810A5 (es)
DK (1) DK220983A (es)
EG (1) EG16042A (es)
ES (1) ES522561A0 (es)
FI (1) FI831746L (es)
GR (1) GR79259B (es)
HU (1) HU192955B (es)
PH (1) PH21382A (es)
PL (1) PL242096A1 (es)
PT (1) PT76701B (es)
RO (1) RO86721B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA883887B (en) * 1987-06-10 1990-02-28 Lilly Co Eli Chromatographic purification process
US4977083A (en) * 1988-04-11 1990-12-11 Eli Lilly And Company Processes for preparing A54145 compounds
US5140101A (en) * 1990-11-21 1992-08-18 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
US5256548A (en) * 1990-11-21 1993-10-26 Bristol-Myers Squibb Company Antiviral antibiotic BU-4344V
CA2394313A1 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Novel lipopeptides as antibacterial agents
BR0016467A (pt) * 1999-12-15 2002-08-27 Cubist Pharm Inc Lipopeptìdeos como agentes antibacterianos
WO2001044272A2 (en) * 1999-12-15 2001-06-21 Cubist Pharmaceuticals, Inc. Daptomycin analogs as antibacterial agents
EP1932853A1 (en) 2001-08-06 2008-06-18 Cubist Pharmaceutical Inc. Novel depsipeptides and process for preparing same
DE60232158D1 (de) 2001-08-06 2009-06-10 Cubist Pharm Inc Lipopeptid-stereoisomere, verfahren zu ihrer herstellung und nützliche zwischenprodukte
US20060004185A1 (en) * 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
PL2379580T3 (pl) * 2008-12-22 2014-05-30 Merck Sharp & Dohme Nowe środki przeciwbakteryjne do leczenia zakażeń wywołanych bakteriami Gram-dodatnimi
NZ593892A (en) * 2008-12-23 2013-11-29 Biosource Pharm Inc Antibiotic compositions for the treatment of gram negative infections
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
US11174288B2 (en) 2016-12-06 2021-11-16 Northeastern University Heparin-binding cationic peptide self-assembling peptide amphiphiles useful against drug-resistant bacteria

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3150059A (en) * 1962-12-26 1964-09-22 Lilly Co Eli Penicillin deacylation via actinoplanaceae fermentation
US4208403A (en) * 1978-10-16 1980-06-17 Eli Lilly And Company A-21978 Antibiotics and process for their production
US4293489A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912A nucleus
US4289692A (en) * 1979-12-13 1981-09-15 Eli Lilly And Company Derivatives of A-30912D nucleus
US4297277A (en) * 1979-12-13 1981-10-27 Eli Lilly And Company Derivatives of A-30912B nucleus
US4293484A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of A-30912H nucleus
US4293482A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company A-30912A Nucleus
US4293486A (en) * 1979-12-13 1981-10-06 Eli Lilly And Company Derivatives of S31794/F-1 nucleus

Also Published As

Publication number Publication date
RO86721A (ro) 1985-04-17
AT380022B (de) 1986-03-25
DD209810A5 (de) 1984-05-23
EG16042A (en) 1986-12-30
ATA178383A (de) 1985-08-15
FI831746A0 (fi) 1983-05-18
US4399067A (en) 1983-08-16
CA1215043A (en) 1986-12-09
FI831746L (fi) 1983-11-22
PL242096A1 (en) 1984-07-02
GR79259B (es) 1984-10-22
ES522561A0 (es) 1984-09-01
HU192955B (en) 1987-08-28
PT76701B (en) 1986-03-27
DK220983D0 (da) 1983-05-18
KR860002185B1 (ko) 1986-12-24
RO86721B (ro) 1985-05-01
DK220983A (da) 1983-11-22
PT76701A (en) 1983-06-01
KR840005076A (ko) 1984-11-03
PH21382A (en) 1987-10-15

Similar Documents

Publication Publication Date Title
ES8407012A1 (es) Un procedimiento para la preparacion del derivado peptidico ciclico a-21978c.
ATE12224T1 (de) Verbindungen mit antifibrinolytischer wirksamkeit.
ES439172A1 (es) Procedimiento para la obtencion de agentes herbicidas.
ES8605821A1 (es) Un procedimiento para la preparacion de aciltripeptidos in- munoestimulantes
AU7991782A (en) 2-penem antibiotics and their oxa-aza-, and carba analogues
ZA803251B (en) Pyroglutamic acid derivatives and analogs
PH15864A (en) 2-(2-alkoxy-methyl)-2-hydroxy-6-7 benzomorphans and salts thereof
ES467601A1 (es) Procedimiento para la preparacion de derivados de cefem.
ES8702433A1 (es) Un procedimiento para la preparacion de un compuesto heterociclico sustituido con peptidos.
ES2132245T3 (es) Derivados de 1-azaadamantano como agonistas o antagonistas de 5-ht.
ES8200887A1 (es) Procedimiento para la preparacion de nuevas 2-(perhi- dro-1,4-diazino)-pirimido(5,4-d)pirimidinas
ES8706129A1 (es) Un procedimiento para la preparacion de derivados de imidazol triciclicos
ES8200113A1 (es) Un procedimiento para la preparacion de derivados de cefalosporina.
GB2159149B (en) 1 2 4-thiadiazines
YU200791A (sh) Trifluorometil 1-karba (1-detia) cefemi
ES2112994T3 (es) Analogos de clomifeno no metabolizables utilizados en el tratamiento de tumores resistentes al tamoxifeno.
IE41804L (en) Substituted but-2-enoanilides, herbicides
ES2002303A6 (es) Procedimiento para preparar nuevos antibioticos de carbapenem-2-sustituidos.
US4010175A (en) Thio-{62 -lactam penicillins
IT8319803A0 (it) Mezzi di fissaggio per fissare una canna ad un corpo di un'arma da fuoco.
ES479378A1 (es) Un procedimiento para la preparacion de compuestos de cefa- losporina.
DK439286D0 (da) Propanolderivater
SE8704551D0 (sv) New benzo(g)quinolines
ES8306154A1 (es) "procedimiento para la preparacion de nuevas 6 -metoxi-penicilinas".
ES8407044A1 (es) "un procedimiento para preparar nuevos compuestos de urea"